---
title: "Dofetilide - Atrial Fibrillation"
sidebar: mydoc_sidebar
permalink: db00204-mesh-d001281-1.html
toc: false 
---


Path ID: `DB00204_MESH_D001281_1`
{% include image.html url="images/db00204-mesh-d001281-1.png" file="db00204-mesh-d001281-1.png" alt="db00204-mesh-d001281-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C063533">MESH:C063533 </a> | dofetilide | Drug |
| <a href="https://identifiers.org/UniProt:Q12809">UniProt:Q12809 </a> | Potassium voltage-gated channel subfamily H member 2 | Protein |
| <a href="https://identifiers.org/UniProt:O95069">UniProt:O95069 </a> | Potassium channel subfamily K member 2 | Protein |
| <a href="https://identifiers.org/UniProt:Q14500">UniProt:Q14500 </a> | ATP-sensitive inward rectifier potassium channel 12 | Protein |
| <a href="https://identifiers.org/GO:0030322">GO:0030322 </a> | stabilization of membrane potential | BiologicalProcess |
| <a href="https://identifiers.org/GO:0061337">GO:0061337 </a> | cardiac conduction | BiologicalProcess |
| <a href="https://identifiers.org/reactome:R-HSA-5576890">reactome:R-HSA-5576890 </a> | Phase 3 - rapid repolarisation | Pathway |
| <a href="https://identifiers.org/MESH:D012032">MESH:D012032 </a> | Refractory Period, Electrophysiological | BiologicalProcess |
| <a href="https://identifiers.org/HP:0001692">HP:0001692 </a> | Atrial arrhythmia | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D001281">MESH:D001281 </a> | Atrial fibrillation | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dofetilide | NEGATIVELY REGULATES | Potassium Voltage-Gated Channel Subfamily H Member 2 |
| Dofetilide | NEGATIVELY REGULATES | Potassium Channel Subfamily K Member 2 |
| Dofetilide | NEGATIVELY REGULATES | Atp-Sensitive Inward Rectifier Potassium Channel 12 |
| Potassium Voltage-Gated Channel Subfamily H Member 2 | PARTICIPATES IN | Phase 3 - Rapid Repolarisation |
| Potassium Channel Subfamily K Member 2 | REGULATES | Stabilization Of Membrane Potential |
| Atp-Sensitive Inward Rectifier Potassium Channel 12 | POSITIVELY REGULATES | Cardiac Conduction |
| Phase 3 - Rapid Repolarisation | NEGATIVELY CORRELATED WITH | Refractory Period, Electrophysiological |
| Stabilization Of Membrane Potential | NEGATIVELY CORRELATED WITH | Refractory Period, Electrophysiological |
| Cardiac Conduction | NEGATIVELY CORRELATED WITH | Refractory Period, Electrophysiological |
| Refractory Period, Electrophysiological | NEGATIVELY CORRELATED WITH | Atrial Arrhythmia |
| Atrial Arrhythmia | MANIFESTATION OF | Atrial Fibrillation |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00204#mechanism-of-action](https://go.drugbank.com/drugs/DB00204#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Dofetilide#Mechanism_of_action](https://en.wikipedia.org/wiki/Dofetilide#Mechanism_of_action)
  - [https://www.cvpharmacology.com/antiarrhy/potassium-blockers](https://www.cvpharmacology.com/antiarrhy/potassium-blockers)
  - [https://pubmed.ncbi.nlm.nih.gov/10907968/](https://pubmed.ncbi.nlm.nih.gov/10907968/)
